Celyad Announces April 2019 Investor Conference Schedule

Celyad Announces April 2019 Investor Conference Schedule

Celyad Reports Business Update and Full Year 2018 Financial and Operating Results

Celyad Reports Business Update and Full Year 2018 Financial and Operating Results

Celyad Appoints Filippo Petti as Chief Executive Officer

Celyad Appoints Filippo Petti as Chief Executive Officer

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Celyad to Announce Full Year 2018 Financial Results and Host Conference Call

Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City

Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City

Celyad Appoints Anne Moore as Vice President Corporate Strategy

Celyad Appoints Anne Moore as Vice President Corporate Strategy

Celyad Announces February and March 2019 Investor Conference Schedule

Celyad Announces February and March 2019 Investor Conference Schedule

Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS

Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS

Celyad Announces Third Quarter 2018 Business Update

Celyad Announces Third Quarter 2018 Business Update

Celyad to Participate at Upcoming Healthcare Conferences

Celyad to Participate at Upcoming Healthcare Conferences

Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting

Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting

Celyad to Present New CYAD-01 Data from THINK Study in Relapsed/Refractory Acute Myeloid Leukemia at 2018 ASH Annual Meeting

Celyad to Present New CYAD-01 Data from THINK Study in Relapsed/Refractory Acute Myeloid Leukemia at 2018 ASH Annual Meeting